0001179110-19-008043.txt : 20190624
0001179110-19-008043.hdr.sgml : 20190624
20190624102548
ACCESSION NUMBER: 0001179110-19-008043
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190620
FILED AS OF DATE: 20190624
DATE AS OF CHANGE: 20190624
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCCLUSKI STEPHEN C
CENTRAL INDEX KEY: 0001188728
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17999
FILM NUMBER: 19913918
MAIL ADDRESS:
STREET 1: 80 ARKAY DRIVE
CITY: HAUPPAUGE
STATE: NY
ZIP: 11788
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMUNOGEN INC
CENTRAL INDEX KEY: 0000855654
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 042726691
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 WINTER ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781)895-0600
MAIL ADDRESS:
STREET 1: 830 WINTER ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
edgar.xml
FORM 4 -
X0306
4
2019-06-20
0
0000855654
IMMUNOGEN INC
IMGN
0001188728
MCCLUSKI STEPHEN C
10 GRANDHILL WAY
PITTSFORD
NY
14534
1
0
0
0
Deferred Share Unit
0
2019-06-20
4
A
0
4000
0
A
2019-09-01
Common Stock
4000
58458
D
Stock Option (right to buy)
2.10
2019-06-20
4
A
0
18000
2.1
A
2019-09-01
2029-06-20
Common Stock
18000
18000
D
The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis.
The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors.
The deferred share units vest quarterly on 9/1/19, 12/1/19, 3/1/20 and 6/1/20, contingent upon the individual remaining a director as of each vesting date.
Exercisable as to 4,500 shares on 9/1/19, 12/1/19, 3/1/20 and 6/1/20, contingent upon the individual remaining a director as of each vesting date.
/s/ Craig Barrows, attorney in fact
2019-06-24